Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT)

Medicines Assessment Research Unit, University of Aberdeen, Aberdeen, Scotland, United Kingdom.

OBJECTIVES: This report presents the 5-year results of the Grampian Region Early Anistreplase Trial (GREAT) and quantifies the benefit of earlier thrombolysis in terms that are generally applicable. BACKGROUND: Although it is accepted that the earlier thrombolytic therapy is given for acute myocardial infarction the greater the benefit, there are widely differing estimates of the magnitude of the time-related benefit of thrombolysis because of inappropriate trial design and analysis. METHODS: In a previously reported randomized trial, anistreplase (30 U) was given intravenously either before hospital admission or in the hospital, at a median time of 105 and 240 min, respectively, after onset of symptoms. Intention to treat and multivariate analyses of the 5-year results were performed. RESULTS: By 5 years, 41 (25%) of 163 patients had died in the prehospital treatment group compared with 53 (36%) of 148 in the hospital treatment group (log-rank test, p < 0.025). Delaying thrombolytic treatment by 1 h increases the hazard ratio of death by 20%, equivalent to the loss of 43/1,000 lives within the next 5 years (95% confidence interval 7 to 88, p = 0.012). Delaying thrombolytic treatment by 30 min reduces the average expectation of life by approximately 1 year. CONCLUSIONS: The magnitude of the benefit from earlier thrombolysis is such that giving thrombolytic therapy to patients with acute myocardial infarction should be accorded the same degree of urgency as treatment of cardiac arrest. Policies should be developed for giving thrombolytic therapy on-site if practicable and by the first qualified person to see the patient.

This article has been cited by other articles:

				K. Dracup, S. McKinley, B. Riegel, D. K. Moser, H. Meischke, L. V. Doering, P. Davidson, S. M. Paul, H. Baker, and M. Pelter A Randomized Clinical Trial to Reduce Patient Prehospital Delay to Treatment in Acute Coronary Syndrome Circ Cardiovasc Qual Outcomes, November 1, 2009; 2(6): 524 - 532. [Abstract] [Full Text] [PDF]

				L Jackson, J Kendall, and N Castle Does prehospital thrombolysis increase the proportion of patients who have an aborted myocardial infarction? Emerg. Med. J., March 1, 2009; 26(3): 206 - 209. [Abstract] [Full Text] [PDF]

				P Gilligan, S Winder, I Singh, V Gupta, P O Kelly, and D Hegarty The Boarders in the Emergency Department (BED) study Emerg. Med. J., May 1, 2008; 25(5): 265 - 269. [Abstract] [Full Text] [PDF]

				P G Steg, J-P Cambou, P Goldstein, E Durand, P Sauval, Z Kadri, D Blanchard, J-M Lablanche, P Gueret, Y Cottin, et al. Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry Heart, October 1, 2006; 92(10): 1378 - 1383. [Abstract] [Full Text] [PDF]

				D Gray Thrombolysis: past, present, and future. Postgrad. Med. J., June 1, 2006; 82(968): 372 - 375. [Abstract] [Full Text] [PDF]

				Part 8: Stabilization of the Patient With Acute Coronary Syndromes Circulation, December 13, 2005; 112(24_suppl): IV-89 - IV-110. [Full Text] [PDF]

				M Woollard, K Pitt, A J Hayward, and N C Taylor Limited benefits of ambulance telemetry in delivering early thrombolysis: a randomised controlled trial Emerg. Med. J., March 1, 2005; 22(3): 209 - 215. [Abstract] [Full Text] [PDF]

				L. Wallentin, P. Goldstein, P.W. Armstrong, C.B. Granger, A.A.J. Adgey, H.R. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Makijarvi, et al. Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction Circulation, July 15, 2003; 108(2): 135 - 142. [Abstract] [Full Text] [PDF]

				D. K Pedley, K. Bissett, E. M Connolly, C. G Goodman, I. Golding, T H Pringle, G P McNeill, S D Pringle, and M C Jones Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics BMJ, July 3, 2003; 327(7405): 22 - 26. [Abstract] [Full Text] [PDF]

				T. Kukulski, F. Jamal, L. Herbots, J. D'hooge, B. Bijnens, L. Hatle, I. De Scheerder, and G. R. Sutherland Identification of acutely ischemic myocardium using ultrasonic strain measurements: A clinical study in patients undergoing coronary angioplasty J. Am. Coll. Cardiol., March 5, 2003; 41(5): 810 - 819. [Abstract] [Full Text] [PDF]

				M. J. Schull, L. J. Morrison, M. Vermeulen, and D. A. Redelmeier Emergency department overcrowding and ambulance transport delays for patients with chest pain Can. Med. Assoc. J., February 4, 2003; 168(3): 277 - 283. [Abstract] [Full Text] [PDF]

				P. Widimsky, T. Budesinsky, D. Vorac, L. Groch, M. Zelizko, M. Aschermann, M. Branny, J. St'asek, P. Formanek, and on behalf of the 'PRAGUE' Study Group Investigator Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial--PRAGUE-2 Eur. Heart J., January 1, 2003; 24(1): 94 - 104. [Abstract] [Full Text] [PDF]

				D T Stephenson, J W Wardrope, and S W Goodacre Is prehospital thrombolysis for acute myocardial infarction warranted in the urban setting? The case against Emerg. Med. J., September 1, 2002; 19(5): 444 - 447. [Abstract] [Full Text] [PDF]

				E.M. Antman, H.A. Cooper, C.M. Gibson, J.A. de Lemos, C.H. McCabe, R.P. Giugliano, P. Coussement, S. Murphy, J. Scherer, K. Anderson, et al. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II Eur. Heart J., June 2, 2002; 23(12): 928 - 933. [Abstract] [Full Text] [PDF]

				K Pitt Prehospital selection of patients for thrombolysis by paramedics Emerg. Med. J., May 1, 2002; 19(3): 260 - 263. [Abstract] [Full Text] [PDF]

				G. W. Stone, D. Cox, E. Garcia, B. R. Brodie, M.-C. Morice, J. Griffin, L. Mattos, A. J. Lansky, W. W. O'Neill, and C. L. Grines Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials Circulation, August 7, 2001; 104(6): 636 - 641. [Abstract] [Full Text] [PDF]

				W. J PENNY Patient delay in calling for help: the weakest link in the chain of survival? Heart, February 1, 2001; 85(2): 121 - 122. [Full Text]

				W S Leslie, A Urie, J Hooper, and C E Morrison Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care Heart, August 1, 2000; 84(2): 137 - 141. [Abstract] [Full Text] [PDF]

				C T Hourigan, D Mountain, P E Langton, I G Jacobs, I R Rogers, G A Jelinek, and P L Thompson Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time Heart, August 1, 2000; 84(2): 157 - 163. [Abstract] [Full Text] [PDF]

				P. Widimsky, L. Groch, M. Zelizko, M. Aschermann, F. Bednar, and H. Suryapranata Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study Eur. Heart J., May 2, 2000; 21(10): 823 - 831. [Abstract] [PDF]

				E. Boersma, M. Akkerhuis, M. L. Simoons, F. Zijlstra, M.-J. de Boer, D. P. Faxon, and J. W. Heger Primary Angioplasty versus Thrombolysis for Acute Myocardial Infarction N. Engl. J. Med., March 23, 2000; 342(12): 890 - 892. [Full Text]

				G. A. Ewy and J. P. Ornato Emergency cardiac care: introduction J. Am. Coll. Cardiol., March 15, 2000; 35(4): 825 - 880. [Full Text] [PDF]

				J. Rawles, C. F. Lundergan, and A. M. Ross Extended Mortality Benefit of Early Postinfarction Reperfusion • Response Circulation, December 22, 1998; 98 (25): 2932 - 2935. [Full Text] [PDF]

				B. R. Brodie, T. D. Stuckey, T. C. Wall, G. Kissling, C. J. Hansen, D. B. Muncy, R. A. Weintraub, and T. A. Kelly Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1312 - 1319. [Abstract] [Full Text] [PDF]

				J. Rawles, C. Sinclair, K. Jennings, L. Ritchie, and N. Waugh Call to needle times after acute myocardial infarction in urban and rural areas in northeast Scotland: prospective observational study BMJ, August 29, 1998; 317(7158): 576 - 578. [Abstract] [Full Text]

				Does Prehospital Thrombolysis Reduce Long-Term MI Deaths? Journal Watch Emergency Medicine, January 1, 1998; 1998(101): 3 - 3. [Full Text]